共 59 条
[1]
Kaplan N.M., Systemic hypertension: Mechanisms and diagnosis, Heart Disease: A Textbook of Cardiovascular Medicine, Edn 5, pp. 807-839, (1997)
[2]
Camm A.J., Cardiovascular medicine, Clinical Medicine, Edn 3, pp. 521-630, (1994)
[3]
Frohlich E.D., Current clinical pathophysiologic consideration in hypertension, Med Clin North Am, 81, pp. 1113-1129, (1997)
[4]
Gavras I., Manolis A., Gavras H., Drug therapy for hypertension, Am Fam Physician, 55, pp. 1823-1834, (1997)
[5]
White P.C., Mune T., Agarwal A.K., B-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess, Endocrine Rev, 18, pp. 135-156, (1997)
[6]
Warnock D.G., Liddle syndrome: An autosomal dominant form of human hypertension, Kidney Int, 53, pp. 18-24, (1998)
[7]
Melander O., Orho M., Fagerudd J., Et al., Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension, Hypertension, 31, pp. 1118-1124, (1998)
[8]
White P.C., Inherited forms of mineralocorticoid hypertension, Hypertension, 28, pp. 927-936, (1996)
[9]
Barlassina C., Citterio L., Bernardi L., Buzzi L., D'Amico M., Sciarrone T., Bianchi G., Genetics of renal mechanisms of primary hypertension: The role of adducin, Journal of Hypertension, 15, 12, pp. 1567-1571, (1997)
[10]
Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzani C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., Bianchi G., Polymorphisms of a-adducin and salt sensitivity in patients with essential hypertension, Lancet, 349, 9062, pp. 1353-1357, (1997)